Page 56 - Read Online
P. 56

Gonzaga-Jauregui et al. Rare Dis Orphan Drugs J 2024;3:6  https://dx.doi.org/10.20517/rdodj.2023.48   Page 7 of 7

               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       Comisión Económica para América Latina y el Caribe (CEPAL). The world has 8 billion people, 662 million of whom live in Latin
                   America and the Caribbean. Available from: https://www.cepal.org/en/news/world-has-8-billion-people-662-million-whom-live-latin-
                   america-and-caribbean [Last accessed on 22 Feb 2024].
               2.       Orphan Drug Act of 1983. US Food and Drug Administration. Public law 97-414 -Jan. 4, 1983. Available from: https://www.govinfo.
                   gov/content/pkg/STATUTE-96/pdf/STATUTE-96-Pg2049.pdf [Last accessed on 22 Feb 2024].
               3.       European Commission. Rare diseases. EU research on rare diseases. Available from: https://ec.europa.eu/info/research-and-innovation/
                   research-area/health-research-and-innovation/rare-diseases_en [Last accessed on 22 Feb 2024].
               4.       Gonzaga-Jauregui C, Lupski JR (Editors). Genomics of rare diseases: understanding disease genetics using genomic approaches. A
                   volume in translational and applied genomics. Amsterdam: Elsevier Inc.; 2021.  DOI
               5.       Haendel M, Vasilevsky N, Unni D, et al. How many rare diseases are there? Nat Rev Drug Discov 2020;19:77-8.  DOI  PubMed  PMC
               6.       Dias AG, Daher A, Barrera Ortiz L, et al. Rarecare: a policy perspective on the burden of rare diseases on caregivers in Latin America.
                   Front Public Health 2023;11:1127713.  DOI  PubMed  PMC
               7.       Forman J, Taruscio D, Llera VA, et al; International Conference for Rare Diseases and Orphan Drugs (ICORD). The need for
                   worldwide policy and action plans for rare diseases. Acta Paediatr 2012;101:805-7.  DOI  PubMed  PMC
               8.       Baynam GS, Groft S, van der Westhuizen FH, et al. A call for global action for rare diseases in Africa. Nat Genet 2020;52:21-6.  DOI
               9.       1er congreso de enfermedades raras de latinoamérica y el caribe - congresoERCAL. Available from:  https://sites.google.com/view/
                   cepcal/proyectos-projetos/congreso-cepcal/1er-congresoercal [Last accessed on 27 Feb 2024].
               10.      United Nations. Resolution adopted by the general assembly on 16 December 2021. Addressing the challenges of persons living with a
                   rare disease and their families. Available from: https://www.rarediseasesinternational.org/wp-content/uploads/2022/01/Final-UN-Text-
                   UN-Resolution-on-Persons-Living-with-a-Rare-Disease-and-their-Families.pdf [Last accessed on 22 Feb 2024].
               11.      World Health Organization. Accelerating access to genomics for global health: promotion, implementation, collaboration, and ethical,
                   legal,  and  social  issues:  a  report  of  the  WHO  Science  Council.  Available  from:  https://www.who.int/publications/i/item/
                   9789240052857 [Last accessed on 22 Feb 2024].
               12.      Giugliani R, Castillo Taucher S, Hafez S, et al. Opportunities and challenges for newborn screening and early diagnosis of rare
                   diseases in Latin America. Front Genet 2022;13:1053559.  DOI  PubMed  PMC
   51   52   53   54   55   56   57   58   59   60   61